House approves bill to speed up Zika drugs

House approves bill to speed up Zika drugs
© Getty Images

The House on Tuesday overwhelmingly approved a bill to offer incentives to companies seeking cures for the Zika virus amid Congress’s growing battle over funding for the epidemic.

ADVERTISEMENT

The bipartisan legislation would add the Zika virus to a list of diseases that qualifies for a “priority review” voucher from the Food and Drug Administration (FDA). It passed the Senate last month.

"This is a significant incentive for private industry to invest the hundreds of millions of dollars and the many man hours it takes to produce a vaccine or treatment," Rep. Susan BrooksSusan Wiant BrooksAl Green says impeachment is 'only solution' to Trump's rhetoric Trump primary challenger Bill Weld responds to rally chants: 'We are in a fight for the soul of the GOP' Democratic strategist on Trump tweets: 'He's feeding this fear and hate' MORE (R-Ind.), one of the bill's authors, said on the House floor.

The bill does not touch the federal funding fight over Zika, which has been bitterly partisan for weeks. It was approved by voice vote.

House Speaker Paul RyanPaul Davis RyanTrump quietly rolled back programs to detect, combat weapons of mass destruction: report Ocasio-Cortez top aide emerges as lightning rod amid Democratic feud Juan Williams: GOP in a panic over Mueller MORE (R-Wis.) praised the FDA bill as a bipartisan effort to “aid the response” and "protect Americans" against Zika, as he and other GOP leaders remain staunchly opposed to adding more funding.

GOP leaders have for months resisted pressure from the Obama administration to approve his nearly $2 billion emergency funding request. Last week, federal health officials announced they would dip into its Ebola funding pool to shore up the response to Zika — a move previously dismissed by the administration.

This week, top officials from the Centers for Disease Control and Prevention and the National Institutes of Health have warned that Congress still needs to act because current funding levels are running dangerously low.

Ryan did not rule out further action on Zika.

“We will continue to monitor the government’s response, and work to protect the American people,” he said in his statement.